Jump to content
IndiaDivine.org

Sinovac Unveils Update On Clinical Trial For H1N1 Vaccine Trials

Rate this topic


Guest guest

Recommended Posts

Guest guest

>>Sinovac has reported that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during the three-day observation of safety, the preliminary tests on the A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans.<<Meaning they didn't drop dead on the spot. Such wonder indeed!=========http://snipurl.com/oqegd [Pharmaceutical Business Review]Sinovac Unveils Update On Clinical Trial For H1N1 Vaccine TrialsPublished:03-August-2009By Staff ReporterPreliminary tests on A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humansSinovac has reported that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during the three-day observation of safety, the preliminary tests on the A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans.Reportedly, a total of 1,614 volunteers, including 101 elders, 706 adults, 404 juvenile and 403 children, had received the first shot of the vaccine through 25 July 2009.The clinical trial is organized by China's Center for Disease Control (CDC), and undertaken by Beijing CDC.In June 2009, the company announced that the Ministry of Health had made an initial order of 4 million doses of Panflu, which is expected to be delivered by the end of September.Sinovac's seasonal influenza vaccine has been released by China SFDA and officially launched to the market at the end of July 2009. =====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

Link to comment
Share on other sites

Guest guest

With all the garbage being shipped here by China can we trust this study. Is their technology up to date and do they really care about saving lives or do they just want to sell 'stuff' to make more money to develop more warfare gadgets?--- On Wed, 8/5/09, Viviane Lerner <vivlerner wrote:

Viviane Lerner <vivlerner Sinovac Unveils Update On Clinical Trial For H1N1 Vaccine Trials"NATURAL NEWS" <insiderCc: "PROGRESSIVE REVIEW" <news, "ALTERNET" <joshua.holland, "HEALTH & HEALING" , "RADTIMES" <resistWednesday, August 5, 2009, 12:12 AM

 

 

>>Sinovac has reported that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during the three-day observation of safety, the preliminary tests on the A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans.<<

Meaning they didn't drop dead on the spot. Such wonder indeed!

=========

http://snipurl.com/oqegd [Pharmaceutical Business Review]

 

Sinovac Unveils Update On Clinical Trial For H1N1 Vaccine Trials

Published:03-August-2009

By Staff Reporter

Preliminary tests on A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans

Sinovac has reported that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during the three-day observation of safety, the preliminary tests on the A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans.

 

Reportedly, a total of 1,614 volunteers, including 101 elders, 706 adults, 404 juvenile and 403 children, had received the first shot of the vaccine through 25 July 2009.

The clinical trial is organized by China's Center for Disease Control (CDC), and undertaken by Beijing CDC.

In June 2009, the company announced that the Ministry of Health had made an initial order of 4 million doses of Panflu, which is expected to be delivered by the end of September.

Sinovac's seasonal influenza vaccine has been released by China SFDA and officially launched to the market at the end of July 2009.

 

 

=====

In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

Link to comment
Share on other sites

Guest guest

The first dose is a set up, the second is the doozie...--- On Wed, 8/5/09, Tony De Angelis <tntstuart wrote:

Tony De Angelis <tntstuartRe: Sinovac Unveils Update On Clinical Trial For H1N1 Vaccine Trials"NATURAL NEWS" <insider, Cc: "PROGRESSIVE REVIEW" <news, "ALTERNET" <joshua.holland, "HEALTH & HEALING" , "RADTIMES" <resistWednesday, August 5, 2009, 6:49 AM

 

 

 

 

With all the garbage being shipped here by China can we trust this study. Is their technology up to date and do they really care about saving lives or do they just want to sell 'stuff' to make more money to develop more warfare gadgets?--- On Wed, 8/5/09, Viviane Lerner <vivlerner (AT) gmail (DOT) com> wrote:

Viviane Lerner <vivlerner (AT) gmail (DOT) com>[Health_and_ Healing] Sinovac Unveils Update On Clinical Trial For H1N1 Vaccine Trials"NATURAL NEWS" <insider@naturalnews .com>Cc: "PROGRESSIVE REVIEW" <news (AT) prorev (DOT) com>, "ALTERNET" <joshua.holland@ alternet. org>, "HEALTH & HEALING" <>, "RADTIMES" <resist (AT) comcast (DOT) net>Wednesday, August 5, 2009, 12:12 AM

 

>>Sinovac has reported that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during the three-day observation of safety, the preliminary tests on the A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans.<<

Meaning they didn't drop dead on the spot. Such wonder indeed! ========= http://snipurl. com/oqegd [Pharmaceutical Business Review]

Sinovac Unveils Update On Clinical Trial For H1N1 Vaccine Trials

Published:03- August-2009

By Staff Reporter Preliminary tests on A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans Sinovac has reported that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during the three-day observation of safety, the preliminary tests on the A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans.

 

Reportedly, a total of 1,614 volunteers, including 101 elders, 706 adults, 404 juvenile and 403 children, had received the first shot of the vaccine through 25 July 2009. The clinical trial is organized by China's Center for Disease Control (CDC), and undertaken by Beijing CDC. In June 2009, the company announced that the Ministry of Health had made an initial order of 4 million doses of Panflu, which is expected to be delivered by the end of September. Sinovac's seasonal influenza vaccine has been released by China SFDA and officially launched to the market at the end of July 2009.

 

=====

In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

Link to comment
Share on other sites

Guest guest

Does the trial vaccine contant the adjuvant? It is my understanding that it does

not. Anyone know? If it does not, common sense says the clinical trials are

worthless.....

 

DebbieA

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...